Evidence map›Paper›PMID 34345598›Full record

ArticleJournal of advanced pharmaceutical technology & research

Anticancer, Antioxidant, and Antibacterial Activities of the Methanolic Extract from

Vivi Mardina, Syafruddin Ilyas, Halimatussakdiah Halimatussakdiah, Tisna Harmawan, Masitta Tanjung, Faridah Yusof

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of advanced pharmaceutical technology & research. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
2.3field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 16 citations in OpenAlex.

  1. International journal of molecular sciences · 2026
    Article
  2. Controlled-ReleaseClinical, cosmetic and investigational dermatology · 2023
    Article
  3. Green synthesis of gold nanoparticles from the aqueous extracts ofJournal of advanced pharmaceutical technology & research
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Vivi MardinaDepartment of Biology, Faculty of Engineering, Universitas Samudra, 24416 Kota Langsa, Aceh, Indonesia.
Syafruddin IlyasDepartment of Biology, Faculty of Mathematics and Natural Sciences, Universitas Sumatera Utara, 20155, Medan, Indonesia.
Halimatussakdiah HalimatussakdiahDepartment of Chemistry, Faculty of Engineering, Universitas Samudra, 24416 Kota Langsa, Aceh, Indonesia.
Tisna HarmawanDepartment of Chemistry, Faculty of Engineering, Universitas Samudra, 24416 Kota Langsa, Aceh, Indonesia.
Masitta TanjungDepartment of Biology, Faculty of Mathematics and Natural Sciences, Universitas Sumatera Utara, 20155, Medan, Indonesia.
Faridah YusofDepartment of Biotechnology Engineering, Faculty of Engineering, International Islamic University Malaysia, Kuala Lumpur 50728, Malaysia.
Samudra University · IDUniversity of North Sumatra · ID

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aims to investigate the potential of bioactive secondary metabolites contained in

Indexed as

AntibacterialantioxidantcytotoxicityMCF-7Wedelia trilobata

Identifiers

PMID34345598
PMCPMC8300329
OpenAlexW3185788039

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.